Bianca Rivera-Pena

4PUBLICATIONS
19CO-AUTHORS
Gene and molecular therapyMolecular targetsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 17, 2026
A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia.

Samarpana Chakraborty, Claudia Morganti, Kimberly Zaldana

|Sep 22, 2021
ASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine.

Nora E Rahmani, Nandini Ramachandra, Srabani Sahu

|Sep 15, 2021
Therapeutic targeting of the inflammasome in myeloid malignancies.

Samarpana Chakraborty, Lauren C Shapiro, Sofia de Oliveira

|Aug 26, 2016
HPV-16 infection modifies overall survival of Puerto Rican HNSCC patients.

Bianca Rivera-Peña, Francisco J Ruíz-Fullana, Germán L Vélez-Reyes

Pageof 1